• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一级亲属中除乳腺癌或卵巢癌外的其他癌症家族史与乳腺癌预后不良有关。

Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis.

作者信息

Song Jun-Long, Chen Chuang, Yuan Jing-Ping, Li Juan-Juan, Sun Sheng-Rong

机构信息

Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China.

Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, 430060, PR China.

出版信息

Breast. 2017 Apr;32:130-134. doi: 10.1016/j.breast.2017.01.016. Epub 2017 Feb 5.

DOI:10.1016/j.breast.2017.01.016
PMID:28178607
Abstract

OBJECTIVE

Whether a first-degree family history of others cancers (FHOC) than breast or ovarian cancer (BOC) is associated with breast cancer prognosis remains unknown. Thus, the aim of the present study was to clarify this issue.

METHODS

Women who were diagnosed with invasive breast cancer at the Renmin Hospital of Wuhan University from 2010 to 2013 were included in the study. The demographic and clinicopathological characteristics of these patients were extracted. FHOC was considered positive for any patient who had a relative who had been diagnosed with cancer other than BOC. Disease-free survival (DFS) was calculated based on the date of diagnosis. DFS was analyzed using the Cox proportional hazards model.

RESULTS

A total of 434 breast cancer patients were included in this study. Among these patients, 61 (14.06%) had a positive FHOC in first-degree relatives. Patients with a positive FHOC tended to have HER2-positive breast cancer (p = 0.03). In the survival analysis, FHOC was associated with poor DFS in both univariate (HR = 2.21 (1.28-3.83), 95% CI: 1.28-3.83, p < 0.01) and multivariate (HR = 2.50, 95% CI: 1.24-5.04, p = 0.01) analyses, especially in patients with luminal A subtypes.

CONCLUSION

The results demonstrated an increased risk of recurrence in breast cancer patients with FHOC, especially in patients with luminal A subtype.

摘要

目的

除乳腺癌或卵巢癌(BOC)外的其他癌症一级家族史(FHOC)是否与乳腺癌预后相关尚不清楚。因此,本研究的目的是阐明这一问题。

方法

纳入2010年至2013年在武汉大学人民医院被诊断为浸润性乳腺癌的女性。提取这些患者的人口统计学和临床病理特征。对于任何有亲属被诊断患有除BOC以外癌症的患者,FHOC被视为阳性。无病生存期(DFS)根据诊断日期计算。使用Cox比例风险模型分析DFS。

结果

本研究共纳入434例乳腺癌患者。在这些患者中,61例(14.06%)一级亲属的FHOC呈阳性。FHOC阳性的患者倾向于患有HER2阳性乳腺癌(p = 0.03)。在生存分析中,单因素(HR = 2.21(1.28 - 3.83),95%CI:1.28 - 3.83,p < 0.01)和多因素(HR = 2.50,95%CI:1.24 - 5.04,p = 0.01)分析中,FHOC均与较差的DFS相关,尤其是在腔面A型亚型患者中。

结论

结果表明,FHOC的乳腺癌患者复发风险增加,尤其是腔面A型亚型患者。

相似文献

1
Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis.一级亲属中除乳腺癌或卵巢癌外的其他癌症家族史与乳腺癌预后不良有关。
Breast. 2017 Apr;32:130-134. doi: 10.1016/j.breast.2017.01.016. Epub 2017 Feb 5.
2
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.CDH1 种系突变患者中遗传性弥漫性胃癌检测标准和结果的准确性。
Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11.
3
Clinical features and survival analysis of T1mic, a, bN0M0 breast cancer.T1mic、a、bN0M0 乳腺癌的临床特征和生存分析。
Jpn J Clin Oncol. 2012 Jun;42(6):471-6. doi: 10.1093/jjco/hys046. Epub 2012 Apr 3.
4
[Clinical characteristics and prognosis of different subtypes of breast cancer].[乳腺癌不同亚型的临床特征与预后]
Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):456-61.
5
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
6
[Clinical features and prognosis analysis of different breast cancer molecular subtypes].不同乳腺癌分子亚型的临床特征及预后分析
Zhonghua Zhong Liu Za Zhi. 2011 Jan;33(1):42-6.
7
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.不同内在型乳腺癌亚型新辅助化疗后病理完全缓解对预后的定义和影响。
J Clin Oncol. 2012 May 20;30(15):1796-804. doi: 10.1200/JCO.2011.38.8595. Epub 2012 Apr 16.
8
[Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].[不同分子亚型可手术乳腺癌患者的临床特征与生存情况]
Zhonghua Zhong Liu Za Zhi. 2009 Jun;31(6):447-51.
9
Raf kinase inhibitory protein role in the molecular subtyping of breast cancer.Raf 激酶抑制蛋白在乳腺癌分子分型中的作用。
J Cell Biochem. 2014 Mar;115(3):488-97. doi: 10.1002/jcb.24682.
10
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.转移性乳腺癌亚型的预后:激素受体/HER2 阳性亚型与最佳结局相关。
Breast Cancer Res Treat. 2013 Oct;141(3):507-14. doi: 10.1007/s10549-013-2711-y. Epub 2013 Oct 9.

引用本文的文献

1
Adjunct Ayurvedic treatment providing more than 10 years of disease-free survival in a rare case of male breast cancer patient with high-grade invasive ductal cell carcinoma - A Case Report.辅助阿育吠陀疗法使一名患有高级别浸润性导管细胞癌的男性乳腺癌罕见病例实现了超过10年的无病生存——病例报告
J Ayurveda Integr Med. 2025 Jan-Feb;16(1):100982. doi: 10.1016/j.jaim.2024.100982. Epub 2025 Jan 25.
2
The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer.厚壁菌门与拟杆菌门的比例作为乳腺癌的一个风险因素
J Clin Med. 2023 Mar 13;12(6):2216. doi: 10.3390/jcm12062216.
3
Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials.
新家族史评分与接受新辅助铂类化疗的乳腺癌患者的病理完全缓解、安全性及生存结局的关联:两项前瞻性试验的探索性分析
EClinicalMedicine. 2021 Jul 17;38:101031. doi: 10.1016/j.eclinm.2021.101031. eCollection 2021 Aug.
4
Correlation between family history and characteristics of breast cancer.家族病史与乳腺癌特征之间的相关性。
Sci Rep. 2021 Mar 18;11(1):6360. doi: 10.1038/s41598-021-85899-8.
5
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study.评估癌症家族史和多种肿瘤诊断在接受PD-1/PD-L1检查点抑制剂治疗的癌症患者中的作用:多中心FAMI-L1研究。
Oncoimmunology. 2020 Jan 7;9(1):1710389. doi: 10.1080/2162402X.2019.1710389. eCollection 2020.
6
[Genital metastases from breast cancer: study of 3 cases and literature review].[乳腺癌的生殖器转移:3例研究及文献综述]
Pan Afr Med J. 2018 May 4;30:7. doi: 10.11604/pamj.2018.30.7.14839. eCollection 2018.